Captek Softgel International, Inc.

Captek Softgel International, Inc. is a US-based manufacturer of dietary supplements specializing in softgel capsules and gummies, delivering innovative health solutions to a diverse clientele. Founded in 1996, Captek Softgel International, Inc. operates from Cerritos, US, focusing on producing dietary supplements.

The company has undergone strategic changes but remains a standalone entity. In August 2022, Swander Pace Capital acquired Captek Softgel International, enhancing its growth strategy. The current CEO is Randy Bridges. CAPTEK® Softgel International, Inc.

specializes in manufacturing dietary supplements, with a focus on softgel capsules and gummies. They produce over 4,000 formulations, including approximately 1,200 active products annually, tailored for both consumers and healthcare providers, emphasizing bioavailability and ingredient stability across multiple regions, including North America, Europe, and Asia. CAPTEK® Softgel International generates revenue primarily through B2B transactions with nutraceutical companies and health brands requiring contract manufacturing services for dietary supplements. Their revenue model is based on partnerships for custom formulations and bulk products, with pricing determined by formulation complexity and production volume, while maintaining high quality standards.

Moving forward, Captek plans to drive organic growth initiatives and explore strategic acquisitions with the support of their most recent funding round from August 2022. Specific upcoming products are currently in development, alongside targeted expansion into new markets aimed for 2023, focusing on increasing their presence in emerging regions.